Cargando…
Evaluation of early-phase [(18)F]-florbetaben PET acquisition in clinical routine cases
OBJECTIVES: In recent years several [(18)F]-labelled amyloid PET tracers have been developed and have obtained clinical approval. There is accumulating evidence that early (post injection) acquisitions with these tracers are equally informative as conventional blood flow and metabolism studies for d...
Autores principales: | Daerr, Sonja, Brendel, Matthias, Zach, Christian, Mille, Erik, Schilling, Dorothee, Zacherl, Mathias Johannes, Bürger, Katharina, Danek, Adrian, Pogarell, Oliver, Schildan, Andreas, Patt, Marianne, Barthel, Henryk, Sabri, Osama, Bartenstein, Peter, Rominger, Axel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5257027/ https://www.ncbi.nlm.nih.gov/pubmed/28138429 http://dx.doi.org/10.1016/j.nicl.2016.10.005 |
Ejemplares similares
-
Beta-amyloid imaging with florbetaben
por: Sabri, Osama, et al.
Publicado: (2015) -
Feasibility of in vivo (18)F-florbetaben PET/MR imaging of human carotid amyloid-β
por: Bucerius, Jan, et al.
Publicado: (2017) -
Ethnic comparison of pharmacokinetics of (18)F-florbetaben, a PET tracer for beta-amyloid imaging, in healthy Caucasian and Japanese subjects
por: Senda, Michio, et al.
Publicado: (2014) -
Colocalization of Tau but Not β-Amyloid with Cortical Superficial Siderosis in a Case with Probable CAA
por: Brendel, Matthias, et al.
Publicado: (2020) -
Optimized classification of (18)F-Florbetaben PET scans as positive and negative using an SUVR quantitative approach and comparison to visual assessment
por: Bullich, Santiago, et al.
Publicado: (2017)